MedTrace Logo

Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy

NCT03761160 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-06-22

No results posted yet for this study

Summary

This research study seeks to develop and evaluate a mobile health app which aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habits.

Conditions

Interventions

OTHER

Mobile Health App

mobile health app aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habit

OTHER

Usual care

Usual care per hospital guidelines

Sponsors & Collaborators

Principal Investigators

  • QUOC-DIEN TRINH, MD · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-16
Primary Completion
2020-01-28
Completion
2020-07-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03761160 on ClinicalTrials.gov